Franklin Genomic Advancements ETF

What is Franklin Genomic Advancements ETF (HELX) stock price today?

As of Jan 15, 2026, 4:51 PM UTC, Franklin Genomic Advancements ETF (HELX) stock is trading at $37.39. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date HELX stock quotes for informed trading decisions.

What is Franklin Genomic Advancements ETF's market capitalization?

Franklin Genomic Advancements ETF (HELX) has a market capitalization of approximately $18.6M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Franklin Genomic Advancements ETF's size relative to other companies in the USD market. The market cap figure updates automatically as the HELX stock price changes.

What is the 52-week range for Franklin Genomic Advancements ETF stock?

Franklin Genomic Advancements ETF (HELX) stock has traded in a 52-week range of $23.74 — $38.17. The 52-week range shows the highest and lowest prices at which HELX traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Franklin Genomic Advancements ETF stock price to this range provides context for recent price action.

How much trading volume does Franklin Genomic Advancements ETF stock have?

Franklin Genomic Advancements ETF (HELX) stock recently traded approximately 1.7K shares. Trading volume indicates market liquidity and investor interest in HELX. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Franklin Genomic Advancements ETF stock.

Does Franklin Genomic Advancements ETF pay dividends to shareholders?

Yes, Franklin Genomic Advancements ETF (HELX) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Franklin Genomic Advancements ETF stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Franklin Genomic Advancements ETF's intraday price range?

Today, Franklin Genomic Advancements ETF (HELX) stock has traded in a range of $37.39 — $37.39. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring HELX's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Franklin Genomic Advancements ETF stock data?

AlphaPilot sources real-time HELX stock quotes, fundamental financial data, and historical price charts for Franklin Genomic Advancements ETF from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Franklin Genomic Advancements ETF stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of HELX stock performance.